Showing results (181-190 of 199) with videos related to
Sort By:
Pageof 20
Cancer Chemotherapy and Pharmacology|October 28, 2017
Efficacy of depatuxizumab mafodotin (ABT-414) monotherapy in patients with EGFR-amplified, recurrent glioblastoma: results from a multi-center, international studyMartin van den Bent, Hui K Gan, Andrew B Lassman, et al.Nature Genetics|August 7, 2013
The integrated landscape of driver genomic alterations in glioblastomaVeronique Frattini, Vladimir Trifonov, Joseph Minhow Chan, et al.Radiology|February 9, 2013
MR imaging predictors of molecular profile and survival: multi-institutional study of the TCGA glioblastoma data setDavid A Gutman, Lee A D Cooper, Scott N Hwang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 26, 2015
A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma PatientsEudocia Q Lee, Thomas J Kaley, Dan G Duda, et al.Neuro-Oncology|February 25, 2022
Detection of tumor-specific DNA methylation markers in the blood of patients with pituitary neuroendocrine tumorsGrayson A Herrgott, Karam P Asmaro, Michael Wells, et al.Science Translational Medicine|June 3, 2016
Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade gliomaTimothy F Cloughesy, Joseph Landolfi, Daniel J Hogan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2026
Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform TrialPatrick Y Wen, Donald A Berry, Meredith B Buxton, et al.Cancer Cell|July 12, 2017
Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the MicroenvironmentQianghu Wang, Baoli Hu, Xin Hu, et al.JCO Precision Oncology|September 14, 2020
Exploring Predictors of Response to Dacomitinib in EGFR-Amplified Recurrent GlioblastomaAndrew S Chi, Daniel P Cahill, David A Reardon, et al.Nature Communications|September 13, 2023
Detection of diagnostic and prognostic methylation-based signatures in liquid biopsy specimens from patients with meningiomasGrayson A Herrgott, James M Snyder, Ruicong She, et al.Pageof 20